Anne Kantardjieff currently serves as Director of Plasmids and Small Molecules within the Vector Manufacturing group at bluebird bio. Prior to that, she was the Director of Early Stage Process Development at Alexion Pharmaceuticals, where her team was responsible for Cell Line Development, as well as Upstream and Downstream Process Development for Alexion’s early clinical biologics portfolio. She is very active in the biologics process development community, recently serving as Industrial Chair for the National Meeting of the Biotechnology Division of the American Chemical Society and currently holds the position of Secretary for the same division. She obtained her Ph.D. in Chemical Engineering from the University of Minnesota, and her B.Eng. in Chemical Engineering from McGill University.